BNP Paribas Financial Markets’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.8M Sell
1,225,135
-222,939
-15% -$6.15M 0.02% 582
2025
Q1
$41.1M Buy
1,448,074
+210,057
+17% +$5.96M 0.02% 524
2024
Q4
$51.5M Buy
1,238,017
+13,840
+1% +$575K 0.03% 457
2024
Q3
$81.8M Buy
1,224,177
+486,061
+66% +$32.5M 0.06% 250
2024
Q2
$87.7M Sell
738,116
-8,776
-1% -$1.04M 0.07% 204
2024
Q1
$79.6M Buy
746,892
+55,237
+8% +$5.89M 0.07% 223
2023
Q4
$68.8M Buy
691,655
+33,374
+5% +$3.32M 0.08% 181
2023
Q3
$68M Sell
658,281
-100,668
-13% -$10.4M 0.09% 154
2023
Q2
$92.2M Buy
758,949
+239,878
+46% +$29.1M 0.12% 121
2023
Q1
$79.7M Sell
519,071
-42,395
-8% -$6.51M 0.11% 122
2022
Q4
$101M Buy
561,466
+116,069
+26% +$20.8M 0.16% 80
2022
Q3
$52.7M Sell
445,397
-29,045
-6% -$3.43M 0.08% 153
2022
Q2
$67.8M Sell
474,442
-61,864
-12% -$8.84M 0.11% 137
2022
Q1
$92.4M Buy
536,306
+202,554
+61% +$34.9M 0.12% 96
2021
Q4
$84.8M Buy
333,752
+210,489
+171% +$53.5M 0.12% 100
2021
Q3
$47.4M Sell
123,263
-114,510
-48% -$44.1M 0.07% 189
2021
Q2
$55.9M Sell
237,773
-25,884
-10% -$6.08M 0.07% 199
2021
Q1
$34.5M Buy
263,657
+80,791
+44% +$10.6M 0.05% 259
2020
Q4
$19.1M Sell
182,866
-109,930
-38% -$11.5M 0.04% 322
2020
Q3
$20.7M Buy
292,796
+154,848
+112% +$11M 0.03% 355
2020
Q2
$8.86M Buy
137,948
+100,023
+264% +$6.42M 0.02% 537
2020
Q1
$1.14M Buy
37,925
+19,532
+106% +$585K ﹤0.01% 1354
2019
Q4
$360K Buy
18,393
+10,140
+123% +$198K ﹤0.01% 2037
2019
Q3
$131K Buy
8,253
+7,604
+1,172% +$121K ﹤0.01% 2349
2019
Q2
$9.5K Buy
+649
New +$9.5K ﹤0.01% 3483